Tuhina Neogi is the recipient of the 2022 Clinical Research Award from the Osteoarthritis Research Society International.
The purpose of the OARSI Clinical Research Award is to recognize excellence in clinical research related to osteoarthritis. Research domains include, but are not limited to, areas such as epidemiology and health services research, clinical outcomes, translational research, and therapeutics, encompassing all phases of research having clinical implications; research having been conducted within the last five years.
Dr. Neogi was acknowledged during the Opening Ceremony at the World Congress on April 7, 2022 in Berlin.
From Healio Rheumatology, April 11 issue
Increasing rates of walking, standing or maximum-level activity is associated with reductions in cartilage loss in knee osteoarthritis, according to a speaker at the 2022 OARSI World Congress.
“Physical activity is consistently recommended for managing knee OA,” S. Reza Jafarzadeh, PhD, of the Boston University School of Medicine, said in his presentation.
Reza Jafarzadeh, DVM, MPVM, PhD is an Assistant Professor and Director of the Clinical Research & Data Analysis Core in the Section of Rheumatology. He presented his poster in a plenary session during the OARSI 2022 World Congress on Osteoarthritis in Berlin, Germany.
From Healio Rheumatology April 8, 2022 issue
Wearable devices demonstrate strong reliability in assessing gait and standing speed in the homes of patients with osteoarthritis, according to findings presented at the 2022 OARSI World Congress.
Wearable technologies to assess disease parameters and outcomes in patient homes have been gaining more widespread use in rheumatology in recent years, partly due to the COVID-19 pandemic, according to Michael J. Rose, BS, of Boston University.
Michael J. Rose, BS, a member of Deepak Kumar's Movement & Applied Imaging Lab at Sargent College, presented virtually his poster at the OARSI 2022 World Congress on Osteoarthritis, held in Berlin. His abstract, Reliability of Wearable Sensors for Assessing Gait and Chair Stand Function at Home in People with Knee Osteoarthritis, was presented during a plenary session of the highest score abstracts submitted.
From the February 25, 2022 issue of Healio Rheumatology
'Horribly mismanaged': Debate over gout treatment rages as cases surge
According to Tuhina Neogi, MD, PhD, professor of medicine and of epidemiology, Alan S. Cohen professor of rheumatology, and chief of rheumatology at the Boston University School of Medicine and Boston Medical Center, gout has been on the rise particularly in developed countries.
“The Global Burden of Disease Study provides some insights about what may be contributing to the doubling of the prevalence of gout in just under 30 years,” Neogi told Healio. “There has been a rise in the global population and increase in life expectancy over that time, but that alone is not sufficient to explain this dramatic increase in gout prevalence.”
Healio Rheumatology article:
'Horribly mismanaged': Debate over gout treatment rages as cases surge
All around the world, gout prevalence is growing at an alarming pace, while gout treatment remains as “horribly mismanaged” as ever.
In this article James O’Dell, MD, Robert L. Grissom Professor of Internal Medicine and Vice Chair and Chief of Rheumatology at the University of Nebraska Medical Center, in Omaha and Tuhina Neogi, MD, PhD, Professor of Medicine and of Epidemiology, Alan S. Cohen Professor of Rheumatology, and Chief of Rheumatology at the Boston University School of Medicine and Boston Medical Center discuss the alarming growth of the prevalence of gout and the mismanagement in its treatment.
Healio on Twitter: @GoHelio
Boston Magazine's annual Top Docs issue for 2022 has hit the newsstands, and 110 BUSM faculty are listed as "tops" in their respective fields.
The directory—created in collaboration with healthcare research firm Castle Connolly Top Doctors—includes 1,797 of the region’s finest physicians, each nominated by their peers and rigorously vetted.
Congratulations to Dr. David Felson, a Boston Magazine Top Doc since 2011, and Dr. Eugene Kissin, a Boston Magazine Top Doc since 2010.
It has been another year of limited gatherings where we can’t get together to express our appreciation for all that you do and continue to do for the Section of Rheumatology and the AADC.
COVID19 and its variants continue to affect how and where we work. But it has not affected how this section has contributed to research and patient care.
I wanted to say a heartfelt thanks to each and every one of you. I would have liked to do this in person, but for our safety and that of our families, we decided to send a newsletter and PowerPoint giving a brief overview of our work, milestones, happy events and updates. Click here to watch the Rheumatology 2021 Holiday Slideshow.
Thank you for your hard work and contributions to the Section of Rheumatology and the AADC. We would not be able to do any of it without all of you as part of our great team!
Wishing you and your loved ones a Joyous and Healthy Holiday and New Year!
2021 APTA MA AWARD WINNER
Clinical Research Award: Joshua Stefanik, MSPT, PhD
Congratulations to Dr. Joshua Stefanik, an Adjunct Assistant Professor in the Section of Rheumatology as a recipient of the Clinical Research Award from the American Physical Therapy Association, Massachusetts Chapter.
APTA Massachusetts is a chapter of the American Physical Therapy Association. The purpose of this award is to give public recognition to APTA MA physical therapists and physical therapist assistant members who are outstanding clinicians, and who have made significant contributions to the profession of physical therapy through the implementation and reporting of quality research.
Dr. Stefanik is a full-time tenure track Assistant Professor of Physical Therapy, Movement and Rehabilitation Sciences at Northeastern University. He is a clinician-scientist who has had tremendous success as a clinical researcher. He has dedicated his research career to investigations related to the epidemiology, mechanisms, biomechanics, and treatments for knee osteoarthritis. Knee osteoarthritis is a serious public health problem, and his work aims to improve the lives of individuals with osteoarthritis by improving their pain and increasing their function.
Dr. Stefanik has received continuous peer reviewed funding (~$1.6 million) from both the NIH and Professional Associations to support his research. He has been extremely productive, with 49 peer-reviewed publications in high impact journals and 64 conference abstract presentations at national and international conferences. In addition to his own research, he is dedicated to training future physical therapists and clinician scientists. He has mentored over 20 Undergraduate, Masters, DPT, and PhD students as well as 4 post-doctoral fellows.
David Felson designated a Robert Dawson Evans Distinguished Professor of Medicine
Congratulations to David Felson, who was named a Robert Dawson Evans Distinguished Professor of Medicine by the Department of Medicine in Boston University.
This honorific designation acknowledges faculty at the professorial rank whose academic achievements have had an exceptional impact on their field in research, education, or clinical care. The award includes a stipend of $125,000 to further support their respective academic programs.
Dr. Felson is one of world’s pre-eminent epidemiologists in osteoarthritis (OA), but occupies a broader role in rheumatology. He has been a champion of rigorous epidemiologic methods. His legacy is best exemplified by his major scientific contributions to the field of osteoarthritis and rheumatology more generally, the numerous trainees and collaborators he has worked with and helped over three decades, his important service to the university and Department of Medicine, and his patients.
Among his contributions in the field of rheumatology are: 1) He was the first to study osteoarthritis, the most common type of arthritis, providing the then novel insight that weight is a major risk factor for knee osteoarthritis; this remains the single most important targetable risk factor for the prevention and management of osteoarthritis. All modern osteoarthritis cohort studies are designed after his first study. 2) He was the first to introduce magnetic resonance imaging (MRI) to the study of knee osteoarthritis. 3) Perhaps his biggest impact has been in the development of the widely used metric for evaluating treatment response in rheumatoid arthritis trials, which is the gold standard outcome measure used by the FDA and other international regulatory agencies, and which has been adapted for numerous other rheumatic diseases. No rheumatologic drug is approved by regulatory agencies worldwide without the outcome measure that he developed.
Dr. Felson’s insights and pursuit of clinically relevant science in rheumatology is complemented by his decades of mentoring to develop the next generation of academic researchers and his service to Boston University School of Medicine. He has mentored numerous individuals who are leaders in their respective fields nationally and internationally who now populate numerous academic institutions across the US and internationally.
Dr. Felson’s contributions have been recognized with prestigious and highest-level awards by the American College of Rheumatology (including as Master of the ACR), the Howley Prize from the Arthritis Foundation (in 2004 and 2020), Osteoarthritis Society Research International, the American Society for Clinical Investigation, and the international Carol Nachman prize in rheumatology. As a testament to his He has also been awarded the Castle Connolly Top Doctor award every year since 2011, an award that is voted by patients and stands as a testament of dedication to, and from, his patients.
We congratulate Dr. Felson on his reception of this distinguished award.
Dr. Felson will be honored during a celebration at the December 21, 2021 Department of Medicine Faculty Meeting.